Advertisement
Screener

AIM IMMUNOTECH INC. (AIM) Retained Earnings

2.8 / 5 stars · 68/120 Roast Me

AIM IMMUNOTECH INC. Retained Earnings

AIM IMMUNOTECH INC. (AIM) had Retained Earnings of -$447.60 million as of 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent

us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-07

  • 2026-06-30: Retained Earnings (Accumulated Deficit) -$447.60M.
  • 2026-03-31: Retained Earnings (Accumulated Deficit) -$443.81M.
  • 2025-12-31: Retained Earnings (Accumulated Deficit) -$440.79M.
  • 2025-09-30: Retained Earnings (Accumulated Deficit) -$436.61M.
Period endRetained Earnings (Accumulated Deficit)Retained Earnings (Accumulated Deficit) as first filed
2026-06-30-$447.60M
10-Q · filed 2026-08-07
2026-03-31-$443.81M
10-Q · filed 2026-05-15
2025-12-31-$440.79M
10-Q · filed 2026-08-07
2025-09-30-$436.61M
10-Q · filed 2025-11-17
2025-06-30-$433.33M
10-Q · filed 2025-08-14
2025-03-31-$430.53M
10-Q · filed 2025-05-15
2024-12-31-$426.83M
10-K · filed 2026-03-27
2024-09-30-$420.86M
10-Q · filed 2024-11-14
2024-06-30-$417.16M
10-Q · filed 2024-08-14
2024-03-31-$415.32M
10-Q · filed 2024-05-15
2023-12-31-$409.51M
10-K · filed 2025-03-27
2023-09-30-$396.93M
10-Q · filed 2023-11-14
2023-06-30-$389.12M
10-Q · filed 2023-08-14
2023-03-31-$384.21M
10-Q · filed 2023-05-15
2022-12-31-$380.55M
10-K · filed 2024-04-01
2022-09-30-$376.16M
10-Q · filed 2022-11-14
2022-06-30-$369.77M
10-Q · filed 2022-08-15
2022-03-31-$364.92M
10-Q · filed 2022-05-13
2021-12-31-$361.10M
10-K · filed 2023-03-31
2021-09-30-$355.25M
10-Q · filed 2021-11-15
2021-06-30-$351.43M
10-Q · filed 2021-08-16
2021-03-31-$345.55M
10-Q · filed 2021-05-17
2020-12-31-$341.97M
10-K · filed 2022-03-31
2020-09-30-$338.57M
10-Q · filed 2020-11-12
2020-06-30-$335.27M
10-Q · filed 2020-08-14
2020-03-31-$331.92M
10-Q · filed 2020-05-14
2019-12-31-$327.57M
10-K · filed 2021-03-31
-$328.11M
10-K · filed 2020-03-30
2019-09-30-$326.92M
10-Q · filed 2019-11-14
2019-06-30-$323.97M
10-Q · filed 2019-08-14
2019-03-31-$321.94M
10-Q · filed 2019-05-15
2018-12-31-$318.58M
10-K · filed 2020-03-30
-$318.57M
10-K · filed 2019-04-01
2018-09-30-$316.97M
10-Q · filed 2018-11-14
2018-06-30-$313.89M
10-Q · filed 2018-08-14
2018-03-31-$311.47M
10-Q · filed 2018-05-15
2017-12-31-$308.76M
10-K · filed 2019-04-01
2017-09-30-$306.77M
10-Q · filed 2017-11-14
2017-06-30-$306.02M
10-Q · filed 2017-08-14
2017-03-31-$303.32M
10-Q · filed 2017-05-15
2016-12-31-$300.50M
10-K · filed 2018-03-30
2016-09-30-$299.33M
10-Q · filed 2016-11-14
2016-06-30-$296.47M
10-Q · filed 2016-08-15
2016-03-31-$295.16M
10-Q · filed 2016-05-16
2015-12-31-$293.00M
10-K · filed 2017-03-31
2015-09-30-$289.86M
10-Q · filed 2015-11-16
2015-06-30-$286.06M
10-Q · filed 2015-08-12
2015-03-31-$281.21M
10-Q · filed 2015-05-12
2014-12-31-$277.77M
10-K · filed 2016-03-29
2014-09-30-$273.31M
10-Q · filed 2014-11-07
2014-06-30-$269.11M
10-Q · filed 2014-08-08
2014-03-31-$264.15M
10-Q · filed 2014-05-09
2013-12-31-$260.32M
10-K · filed 2015-03-19
2013-09-30-$257.12M
10-Q · filed 2013-11-08
2013-06-30-$251.99M
10-Q · filed 2013-08-09
2013-03-31-$247.71M
10-Q · filed 2013-05-08
2012-12-31-$244.09M
10-K · filed 2014-03-14
2012-09-30-$238.63M
10-Q · filed 2012-11-02
2012-06-30-$232.05M
10-Q · filed 2012-08-08
2012-03-31-$229.05M
10-Q · filed 2012-05-07
2011-12-31-$226.74M
10-K · filed 2013-03-18
2011-09-30-$223.63M
10-Q · filed 2011-11-09
2011-06-30-$220.88M
10-Q · filed 2011-08-05
2010-12-31-$217.72M
10-K · filed 2012-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Silexion Therapeutics Corp (SLXN)$0.001B